WaveMan
WaveMan · Company
NIVF · Newgenivf Group Ltd
> Search tickers & screens ⌘K
LIVE
← All companies

NIVF NewGenIvf (NIVF) Insider Trading, Ownership & Congress Trades

Healthcare Services · Services-misc health & allied services, nec · CIK 0001981662
Quote by TradingView
SEC filings
House members buying, 1 year
0
STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
0
13F, latest reported quarter
Conversions, 180 days
4
Codes C/M, not in net · $28 priced

What the filings say about NIVF

Insiders, 180 days
+$4.2M net bought
2 buyers · 1 seller · 0% of sales under a 10b5-1 plan

NewGenIvf insider trades (Form 4)

Form 4 buys and sells (codes P and S). Grants, option exercises and conversions excluded.

Over the last 180 days, NewGenIvf Group Ltd insiders bought a net $4.2M of stock across 10 Form 4 purchases and sales, with 2 insiders buying. Source: SEC Form 4 filings, as of 2026-10-28.

Foreign private issuer: most of its insiders are exempt from SEC Form 4, but some still file it; those filings are listed below, and the record may be incomplete.

Insider
Filed
Shares
Value
Since filing
Cheung Kong Yiu
Director
BUY
2026-09-02 SECtraded 2026-07-27
2,500,000
$2.5M
-1.7%
Context
  • 3 earlier Form 4 trades (code P or S) here by this insider (3 buys), the last on Jun 18, 2026.
  • -51.4% median (-22.4% mean) 90-day return after 3 previous buys.
  • The trade is 67.2% of the 3,722,223 shares held after it.
  • No other insider bought within 30 days.
  • No fund added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Cheung Kong Yiu bought about $2.5M of NIVF on Jul 27, 2026, the largest insider purchase at the company on our record.
Cheung Kong Yiu
Director
BUY
2026-09-02 SECtraded 2026-06-18
500,000
$665.0K
-1.7%
Context
  • 2 earlier Form 4 trades (code P or S) here by this insider (2 buys), the last on Jun 2, 2026.
  • -52.6% median (-52.6% mean) 90-day return after 2 previous buys.
  • The trade is 40.9% of the 1,222,223 shares held after it.
  • 1 other insider bought within 30 days.
  • No fund added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Cheung Kong Yiu bought about $665.0K of NIVF on Jun 18, 2026; 1 other insider bought within 30 days.
HRT FINANCIAL LP
SELL
2026-06-08 SECtraded 2026-06-04
64,945
$50.7K
-21.4%
Context
  • 5 earlier Form 4 trades (code P or S) here by this insider (4 buys, 1 sale), the last on Jun 3, 2026.
  • -46.3% median (-45.3% mean) 90-day return after 4 previous buys.
  • The trade is 358.1% of the 18,134 shares held after it.
  • No other insider sold within 30 days.
  • No fund added in the 13F quarter to Jun 30, 2026.
Insider activity: Insider HRT FINANCIAL LP sold about $50.7K of NIVF on Jun 4, 2026.
HRT FINANCIAL LP
BUY
2026-06-04 SECtraded 2026-06-03
11,738
$10.3K
-39.4%
Context
  • 4 earlier Form 4 trades (code P or S) here by this insider (3 buys, 1 sale), the last on Jun 2, 2026.
  • -45.4% median (-44.6% mean) 90-day return after 3 previous buys.
  • The trade is 14.1% of the 83,079 shares held after it.
  • 1 other insider bought within 30 days.
  • No fund added in the 13F quarter to Jun 30, 2026.
Insider activity: Insider HRT FINANCIAL LP bought about $10.3K of NIVF on Jun 3, 2026; 1 other insider bought within 30 days.
HRT FINANCIAL LP
BUY
2026-06-04 SECtraded 2026-06-02
23,018
$21.6K
-39.4%
Context
  • 3 earlier Form 4 trades (code P or S) here by this insider (2 buys, 1 sale), the last on May 27, 2026.
  • -41.2% median (-41.2% mean) 90-day return after 2 previous buys.
  • The trade is 32.3% of the 71,341 shares held after it.
  • 1 other insider bought within 30 days.
  • No fund added in the 13F quarter to Jun 30, 2026.
Insider activity: Insider HRT FINANCIAL LP bought about $21.6K of NIVF on Jun 2, 2026; 1 other insider bought within 30 days.
10 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
See all insider buying · insider selling
Showing the latest few. to see 5 more transactions and use the screener and CSV export. We store only your email; there is no password.
Seven facts, ranked against the sector · Rank is not a forecast
Insiders
net +$4.2M over 180 days
+$4.2M of it by a 10%+ holder
more than 97% of Healthcare Services
Congress
no House purchase disclosed in the last 12 months
Funds
under five funds report holding it
Revenue
+6278.9% year over year
more than 99% of Healthcare Services
Margin
41.7% net margin
more than 99% of Healthcare Services
Buybacks
no share repurchases reported
Short interest
1.0 days to cover · settled 2026-10-15
What changed in the last 30 days
Oct 28Insider buying stopped: no purchases in 90 days after 8 in the prior 90
Why it matters
The absence is the signal: 8 purchases in one 90-day window and none in the next is a change of behaviour, not a filing.

Watch NIVF

A free account keeps a watchlist and can send one email a day when insiders, funds or Congress file on the names in it. No password and no card.

The year, with the filings on it
Total return over 12 months. Each marker is a filing; hover or tap one for the detail.
-99.5%12M
-100%-66%-33%-0%2025-102025-122026-022026-042026-062026-082026-10 2026-07-27 · Cheung Kong Yiu bought $2.5M2026-06-02 · Cheung Kong Yiu bought $665.0K2026-06-18 · Cheung Kong Yiu bought $665.0K2026-05-28 · Cheung Kong Yiu bought $333.3K2026-05-22 · HRT FINANCIAL LP bought $136.2K2026-05-27 · HRT FINANCIAL LP sold $68.3K2026-06-04 · HRT FINANCIAL LP sold $50.7K2026-05-26 · HRT FINANCIAL LP bought $25.8K2026-06-02 · HRT FINANCIAL LP bought $21.6K2026-06-03 · HRT FINANCIAL LP bought $10.3K
Insider buyInsider sell
Indexed to 100, dividend-adjusted, not a price chart. When a name files heavily, the largest trades are drawn first.

Who owns NIVF: institutional holders (13F)

13F holdings, latest reported quarter
Clear Street Group Inc.
389,270 sh
$11.7K
MMCAP International Inc. SPC
375,000 sh
$11.2K
Walleye Trading LLC
161,871 sh
$4.9K
D. E. Shaw & Co., Inc.
168,750 sh
$4.2K
RIVERNORTH CAPITAL MANAGEMENT, LLC
143,997 sh
$2.8K

Congress trades in NIVF

No Congress trades reported
No House member has disclosed a trade in this stock. See what Congress is buying.

Activist and 5% holders (13D/13G)

No 5%+ ownership filings
Nobody has filed for crossing 5%. That is a fact, not missing data.

NIVF planned insider sales (Form 144)

No planned-sale notices
No insider has filed to sell. Watch this after a run-up.
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
Insiders are net buyers of their own stock.
The record shows a net $4.2M bought by insiders over 180 days. Each figure is a federal filing, dated the day it went public.
Backtest this pattern Open the screener
Same sector, ranked by filing activity
Sector by SEC SIC code
NTRACSTLPGNYHIMSWGSPRVATDOCAVAHGHADUSSERABDSX

NIVF financials

Revenue growth
+6278.9%
XBRL, annual
Net margin
41.7%
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
2025-122024-122023-122022-12
Revenue$23.7M$5.4M$5.1M$5.9M
Gross profit$955.8K$1.8M$1.7M$1.5M
Operating income-$10.7M-$1.2M$42.2K$398.7K
Net income$9.9M-$524.6K$130.2K$458.7K
EPS (diluted)27.36-39,678.88117,173.704.72
Operating cash flow-$10.9M-$8.3M-$1.8M$1.7M
Cash$758.6K$457.7K$54.1K$27.6K
SEC XBRL, fiscal years, as known on 2026-10-28

NIVF Stock Sonar score 3/7 axes

Find similar shapesCompare

NIVF ranks highest on growth (99th percentile) and insider conviction (92nd), and lowest on institutional and government (1st), among Healthcare Services peers.

Growth
99
Inputs
  • Revenue growth, YoY+6279% · 99 pct, sector of 87
  • Backlog growth, YoYno backlog line filed, or no year-earlier backlog
Insider conviction
92
Inputs
  • Net Form 4 buying (codes P and S), 180d$4.2M · 97 pct, sector of 64
  • Insider buyers, 180d2 · 87 pct, sector of 64
Institutional and government
0
Inputs
  • Funds adding, latest quarter0 · 0 pct, sector of 73
  • Congress net buyers, 365dno Congress trades in 365 days
  • Federal contracts, 180dno federal contracts in 180 days
  • Lobbying spend, 4 quartersno lobbying filings in the last four quarters
4 not measured: Profitability, Financial health, Risk and compliance, US patents
  • Profitability needs 2 of 4 inputs, 0 present: fewer than four consecutive quarters of net income; fewer than four consecutive quarters of operating income
  • Financial health needs 1 of 2 inputs, 0 present: no debt line filed
  • Risk and compliance needs 1 of 4 inputs, 0 present: needs two 10-Ks with a Risk Factors section (not 20-F filers or stubs); no short interest or no free float on file; revenue under $50M or not filed, so a count cannot be scaled to size
  • US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet

3 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored

NIVF filings, in plain words

Are NewGenIvf insiders buying or selling NIVF?

In the 180 days to 2026-10-28, NewGenIvf insiders were net buyers, a net $4.2M: $4.4M of purchases and $118.9K of sales reported on Form 4, by 2 buyers and 1 seller.

Read the full summary

In the 180 days to 2026-10-28, NewGenIvf insiders were net buyers of NIVF, a net $4.2M across purchases and sales reported on Form 4 by 2 buyers and 1 seller. Most of that figure, $4.2M, came from a holder of 10% or more rather than an officer or director. Purchases outweighed sales more than tenfold by value. Each figure is counted from SEC and House filings as of 2026-10-28, dated the day the filing was made public.

Explore insider trading and ownership data

Every company we track, ranked by each kind of filing
Insider buyingInsider sellingCongress stock tradesActivist 13D stakesForm 144 planned salesCEO pay vs performanceAll companies